Obstetric hemorrhage

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 8, 2011, Pages 1441-1451

  McLintock, Claire ^a,b   James, A H ^a,b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hemorrhage; Obstetric; Postpartum; Severe; Transfusion

Indexed keywords

FIBRINOGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD BANK; BLOOD TRANSFUSION; CLINICAL FEATURE; DELIVERY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; MATERNAL MORTALITY; OBSTETRIC HEMORRHAGE; PLACENTA ACCRETA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK FACTOR; UTERUS RUPTURE;

BLOOD TRANSFUSION; COAGULANTS; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR VIIA; FEMALE; HEMOSTATIC TECHNIQUES; HUMANS; HYSTERECTOMY; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 80051587962     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04398.x     Document Type: Review

References (71)

1. NCCEMD, Saving Mothers 2005-2007: Fourth Report on Confidential Enquiries into Maternal Deaths in South Africa. Pretoria, SA: South African Department of Health, 2009: 11-47.
2. ACOG. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006; 108: 1039-47.
3. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-74.
4. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, Lopez AD, Lozano R, Murray CJ. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010; 375: 1609-23.
5. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, Joseph KS, Lewis G, Liston RM, Roberts CL, Oats J, Walker J. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009; 9: 55.
6. McCormick ML, Sanghvi HC, Kinzie B, McIntosh N. Preventing postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet 2002; 77: 267-75.
7. Geller SE, Adams MG, Kelly PJ, Kodkany BS, Derman RJ. Postpartum hemorrhage in resource-poor settings. Int J Gynaecol Obstet 2006; 92: 202-11.
8. Miller S, Lester F, Hensleigh P. Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. J Midwifery Womens Health 2004; 49: 283-92.
9. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006; 113: 919-24.
10. Francois KE, Foley MR. Antepartum and postpartum hemorrhage. In: Gabbe S, Niebyl J, Simpson J, eds. Obstetrics: Normal and Problem Pregnancies, 5th edn. Philadelphia, PA: Churchill Livingstone Elsevier, 2007: 456-85.
11. Macphail S, Fitzgerald J. Massive post-partum haemorrhage. Curr Obstet Gynaecol 2001; 11: 108-14.
12. Konje JC, Murphy P, de Chazal R, Davidson A, Taylor D. Severe factor X deficiency and successful pregnancy. Br J Obstet Gynaecol 1994; 101: 910-1.
13. Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: A population-based study. J Matern Fetal Neonatal Med 2005; 18: 149-54.
14. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S. Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175-82.
15. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 2008; 115: 1265-72.
16. Penney G, Kernaghan D, Adamson L. Scottish Confidential Inquiry of Severe Maternal Morbidity 2nd Annual Report. Aberdeen, Scotland: NHS Quality Improvement Scotland, 2004: 32.
17. Penney G, Kernaghan D, Adamson L. Scottish Confidential Inquiry of Severe Maternal Morbidity 3rd Annual Report. Aberdeen, Scotland: NHS Quality Improvement Scotland, 2006: 34.
18. Penney G, Adamson L. Scottish Confidential Audit of Severe Maternal Morbidity: 4th Annual Report 2006. Edinburgh: National Health Service Qualtiy Improvement Scotland, 2007: 1-34.
19. Health Canada: Special Report on Maternal Mortality and Severe Morbidity in Canada. Ottawa: Minister of Public Works and Government Services Canada, 2004: 1-36.
20. Joseph KS, Rouleau J, Kramer MS, Young DC, Liston RM, Baskett TF. Investigation of an increase in postpartum haemorrhage in Canada. BJOG 2007; 114: 751-9.
21. James AH, Paglia MJ, Gernsheimer T, Grotegut C, Thames B. Blood component therapy in postpartum hemorrhage. Transfusion 2009; 49: 2430-3.
22. Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA. Increased postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet 2007; 98: 237-43.
23. SCASMM, Scottish Confidential Audit of Severe Maternal Morbidity: 5th Annual Report 2007. Edinburgh: National Health Service Quality Improvement Scotland, 2009: 1-39.
24. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 2010; 110: 1368-73.
25. Lewis G, ed. Saving Mothers Lives: Reviewing Maternal Deaths to Make Motherhood Safer - 2003-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH, 2007.
26. Rouse DJ, MacPherson C, Landon M, Varner MW, Leveno KJ, Moawad AH, Spong CY, Caritis SN, Meis PJ, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O'Sullivan MJ, Sibai BM, Langer O, Thorp JM, Ramin SM, Mercer BM. Blood transfusion and cesarean delivery. Obstet Gynecol 2006; 108: 891-7.
27. Sosa CG, Althabe F, Belizan JM, Buekens P. Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol 2009; 113: 1313-9.
28. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500ml) and severe (> or = 1000ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2004; 115: 166-72.
29. Grotegut CA, Paglia MJ, Johnson LN, Thames B, James AH. Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony. Am J Obstet Gynecol 2011; 204: 56.e1-6.
30. Kramer MS, Rouleau J, Baskett TF, Joseph KS. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 2006; 368: 1444-8.
31. Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on million births in the United States. Am J Obstet Gynecol 2008; 199: 49.e1-8.
32. Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ. Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol 2010; 115: 910-7.
33. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005; 11: 295-307.
34. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007; 5: 1165-9.
35. Chauleur C, Cochery-Nouvellon E, Mercier E, Aya G, Fabbro-Peray P, Mismetti P, Lissade-Lavigne G, Gris JC. Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages. J Thromb Haemost 2008; 6: 2067-74.
36. James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, Kamphuisen PW, Konkle BA, Martinez-Perez O, McLintock C, Peyvandi F, Winikoff R. von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol 2009; 201: 12.e1-8.
37. James AH. Women and bleeding disorders. Haemophilia 2010; 16(Suppl. 5): 160-7.
38. Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, Delaney M, Duperron L, Girard I, Jones D, Lee LS, Shepherd D, Wilson K. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 2009; 31: 980-93.
39. Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, Wagh K, Patted SS, Naik VA, Moss N, Derman RJ. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet 2006; 93: 220-4.
40. Macphail S, Talks K. Massive post-partum haemorrhage and management of disseminated intravascular coagulation. Curr Obstet Gynaecol 2004; 14: 123-31.
41. Doumouchtsis SK, Papageorghiou AT, Vernier C, Arulkumaran S. Management of postpartum hemorrhage by uterine balloon tamponade: prospective evaluation of effectiveness. Acta Obstet Gynecol Scand 2008; 87: 849-55.
42. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007; 62: 540-7.
43. Knight M. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG 2007; 114: 1380-7.
44. Rossi AC, Lee RH, Chmait RH. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol 2010; 115: 637-44.
45. Sher G. Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy. Am J Obstet Gynecol 1977; 129: 164-70.
46. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5.
47. Murray DJ, Olson J, Strauss R, Tinker JH. Coagulation changes during packed red cell replacement of major blood loss. Anesthesiology, 1988; 69: 839-45.
48. Ciavarella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, Carrico CJ. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67: 365-8.
49. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009; 102: 793-9.
50. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101: 769-73.
51. Hossain N, Paidas M. Disseminated intravascular coagulation. In: Belfort MA, Saade GR, Foley MR, Dildy GA, eds. Critical Care Obstetrics, 5th edn. Hoboken, NJ, USA: Wiley-Blackwell Publishers, 2010: 394-407.
52. Stansbury LG, Dutton RP, Stein DM, Bochicchio GV, Scalea TM, Hess JR. Controversy in trauma resuscitation: do ratios of plasma to red blood cells matter? Transfus Med Rev 2009; 23: 255-65.
53. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-13.
54. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ, Hess JR, Dubick MA, Simon CD, Beekley AC, Wolf SE, Wade CE, Holcomb JB. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64(2 Suppl.): S79-85; discussion S85.
55. Kashuk JL, Moore EE, Johnson JL, Haenel J, Wilson M, Moore JB, Cothren CC, Biffl WL, Banerjee A, Sauaia A. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma 2008; 65: 261-70; discussion 270-1.
56. Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, Cuschieri J, Maier RV, Billiar TR, Peitzman AB. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009; 67: 221-7; discussion 228-30.
57. Hedner U. Factor VIIa in the treatment of haemophilia. Blood Coagul Fibrinolysis 1990; 1: 307-17.
58. Barletta JF, Ahrens CL, Tyburski JG, Wilson RF. A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients. J Trauma 2005; 58: 646-51.
59. Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost 2008; 34: 104-12.
60. Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg, 2009; 109: 1908-15.
61. Alfirevic Z, Elbourne D, Pavord S, Bolte A, van Geijn H, Mercier F, Ahonen J, Bremme K, Bodker B, Magnusdottir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Obstet Gynecol 2007; 110: 1270-8.
62. Nicklin J, Perrin L, Crandon A, Land R, Nascimento M, Obermair A. Re: guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008; 48: 447.
63. Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008; 48: 12-6.
64. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 45.
65. Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008; 100: 792-7.
66. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, Rudigoz RC. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009; 116: 1097-102.
67. Leemann H, Lustenberger T, Talving P, Kobayashi L, Bukur M, Brenni M, Bruesch M, Spahn DR, Keel MJ. The role of rotation thromboelastometry in early prediction of massive transfusion. J Trauma 2010; 69: 1403-8; discussion 1408-9.
68. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194: 1311-5. Epub 2006 Apr 21.
69. Danilenko-Dixon DR, Heit JA, Silverstein MD, Yawn BP, Petterson TM, Lohse CM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol 2001; 184: 104-10.
70. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509-16.
71. James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006; 113: 1564-71. Epub 2006 Mar 13.